STOCK TITAN

Quantum Cyber appoints David Caplon as CFO

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Quantum Cyber N.V. (QUCY) said William Caragol resigned as CFO effective November 20, 2026, and appointed David Caplon as CFO that day. Caragol will consult for $15,000 per month; his previously granted equity awards will continue vesting on existing schedules and remain outstanding and exercisable through their original 10-year terms, regardless of when his services end.

Caplon’s agreement provides a base salary of $22,500 per month ($270,000 annualized), a target annual cash bonus of 100% of base salary tied to performance objectives, and annual equity awards with grant-date value up to the greater of the value of 250,000 ordinary shares or 100% of base salary. He also received a 170,000-share option that vests in 18 substantially equal monthly installments, subject to continued employment.

Filing Explained

If the company terminates Caplon without cause, he dies or becomes disabled, or he leaves for good reason, a release is required for 12 months’ salary, a prorated target bonus, up to 12 months’ COBRA reimbursement, and vesting of awards due in the next 12 months. A company-without-cause or good-reason termination within 12 months after a change in control instead accelerates all unvested awards.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Caragol consulting fee $15,000 per month Consulting agreement entered into November 20, 2026
Caplon base salary $22,500 per month ($270,000 annualized) Employment agreement effective November 20, 2026
Target annual cash bonus 100% of annual base salary Based on achievement of performance objectives
Annual equity awards Grant-date value up to the greater of the value of 250,000 ordinary shares and 100% of annual base salary Under the employment agreement and the company’s 2025 Omnibus Incentive Plan
Promotion option 170,000 ordinary shares Granted November 20, 2026; vests in 18 substantially equal monthly installments, subject to continued employment
Initial agreement term 12 months Automatically renews for successive six-month periods unless either party gives timely written notice of non-renewal
COBRA premiums regulatory
"reimbursement of COBRA premiums for up to twelve months"
change in control technical
"within twelve months following a change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
accelerated vesting financial
"accelerated vesting of the portion of his outstanding unvested equity awards"
A contract feature that makes stock awards, options, or restricted shares become owned or exercisable earlier than the original schedule. It shortens or cancels the waiting period so recipients can sell, transfer, or exercise their equity sooner — think of a timed lock that is unlocked ahead of schedule. It matters to investors because it changes when shares enter the market, who controls them, and how much dilution or ownership concentration happens.
general release of claims technical
"subject to his execution of a general release of claims"
non-solicitation covenants technical
"non-solicitation covenants with respect to the Company’s employees and customers"
Non-solicitation covenants are contractual promises that prohibit a party—often a departing employee or a seller in a deal—from actively reaching out to a company’s customers, clients, or staff to persuade them to leave. Think of it like a “no-poaching” rule that protects relationships and personnel; investors care because such clauses help preserve revenue streams, protect key talent after transactions, and reduce the risk that value is lost through poaching or disrupted customer ties.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is QUCY’s new CFO?

David Caplon became CFO effective November 20, 2026, and will serve as the company’s principal financial officer and principal accounting officer.

What is David Caplon’s salary as QUCY CFO?

His base salary is $22,500 per month, or $270,000 on an annualized basis. He is also eligible for a target annual cash bonus equal to 100% of his annual base salary, based on performance objectives.

How long is David Caplon’s QUCY employment agreement?

The initial term is 12 months from its November 20, 2026 effective date. It automatically renews for successive six-month periods unless either party gives written notice of non-renewal at least 21 days before the current term ends.

What severance terms apply if David Caplon leaves QUCY?

Qualifying terminations can provide 12 months of salary continuation, a prorated target bonus, COBRA premium reimbursement for up to 12 months, and specified equity acceleration, subject to a general release. For a company termination without cause or a resignation for good reason within 12 months after a change in control, all outstanding unvested equity awards vest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001874252 00-0000000 0001874252 2026-11-20 2026-11-20 0001874252 dei:FormerAddressMember 2026-11-20 2026-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 20, 2026

 

Quantum Cyber N.V.

(Exact Name of Registrant as Specified in its Charter)

 

The Netherlands   001-41010   N/A

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

38 Union Avenue, Bridgeport, CT 06607

(Address of Principal Executive Offices) (Zip Code)

 

+1 (203) 851-1599

(Registrant’s telephone number, including area code)

 

200 Connecticut Avenue, Suite 400, Norwalk, CT 06854

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange On Which Registered
Ordinary Shares, nominal value €0.01 per share   QUCY   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Resignation of William Caragol, Chief Financial Officer

 

On November 20, 2026, William Caragol notified Quantum Cyber N.V., a company organized under the laws of the Netherlands (the “Company”), of his resignation as the Company’s Chief Financial Officer, effective November 20, 2026. To support the transition, on November 20, 2026, Mr. Caragol entered into a consulting agreement with the Company, pursuant to which Mr. Caragol will receive a fee of $15,000 per month. In addition, all equity awards previously granted to Mr. Caragol pursuant to the Company’s 2025 Omnibus Incentive Plan (the “Plan”) will continue to vest in accordance with their existing vesting schedules and will remain outstanding and exercisable through their original ten-year terms, regardless of when Mr. Caragol ceases to provide services to the Company.

 

Appointment of David Caplon, Chief Financial Officer

 

In connection with Mr. Caragol’s resignation, on November 20, 2026, the Board of Directors of the Company (the “Board”) appointed David Caplon, age 33, to serve as Chief Financial Officer of the Company, effective November 20, 2026. In such capacity, Mr. Caplon will serve as the Company’s principal financial officer and principal accounting officer.

 

Mr. Caplon has served as the Company’s Controller since June 2026. Upon the effectiveness of his appointment as Chief Financial Officer, Mr. Caplon will no longer serve as Controller. Mr. Caplon has served as Corporate Controller of CapForce Inc. (formerly known as OpGen, Inc.), a capital markets advisory and financial technology company and formerly a molecular diagnostics company, since September 2022, and previously served as its Assistant Controller from March 2021 to September 2022. Mr. Caplon has also provided, and continues to provide, certain accounting and financial reporting services to other companies, none of which has constituted his principal occupation or employment. Mr. Caplon began his career in the audit practice of CohnReznick LLP, a public accounting firm, and subsequently held various corporate accounting and finance positions of increasing responsibility before joining CapForce Inc. Mr. Caplon holds a Bachelor of Science in Accounting and Finance from the University of Maryland, College Park, and is a Certified Public Accountant licensed in the Commonwealth of Virginia.

 

On November 20, 2026, in connection with Mr. Caplon’s appointment as Chief Financial Officer of the Company, the Company and Mr. Caplon entered into an executive employment agreement (the “Employment Agreement”). The Employment Agreement, which becomes effective on November 20, 2026 (the “Effective Date”), provides for, among other things, a base salary of $22,500 per month ($270,000 on an annualized basis), subject to review for increase at least annually. Mr. Caplon will be eligible to receive a target annual cash bonus equal to 100% of his annual base salary, as determined by the Compensation Committee of the Board based on the achievement of performance objectives, and annual equity awards under the Plan with a grant-date value of up to the greater of (i) the value of 250,000 ordinary shares and (ii) 100% of his annual base salary.

 

The Employment Agreement has an initial term of twelve months from the Effective Date and will automatically renew for successive six-month periods unless either party provides written notice of non-renewal at least 21 days before the end of the then-current term. A notice of non-renewal by the Company will be treated as a termination without cause for purposes of Mr. Caplon’s severance. If Mr. Caplon’s employment is terminated by the Company without cause or by reason of his death or disability, or by Mr. Caplon for good reason (each as defined in the Employment Agreement), subject to his execution of a general release of claims, Mr. Caplon will be entitled to (i) continued payment of his base salary for twelve months, (ii) a prorated target annual bonus for the year of termination, (iii) reimbursement of COBRA premiums for up to twelve months and (iv) accelerated vesting of the portion of his outstanding unvested equity awards that would have vested during the twelve months following termination, with vested stock options remaining exercisable for not less than twelve months following termination. Severance payments will cease if Mr. Caplon materially violates his restrictive covenant obligations. If Mr. Caplon’s employment is terminated by the Company without cause or by Mr. Caplon for good reason within twelve months following a change in control (as defined in the Employment Agreement), Mr. Caplon will instead be entitled to the same salary continuation, prorated target bonus and COBRA benefits, plus full vesting of all of his outstanding unvested equity awards. The Employment Agreement also contains confidentiality and intellectual property assignment covenants and non-solicitation covenants with respect to the Company’s employees and customers during the term and for one year following his employment, and provides for indemnification and advancement of expenses to the fullest extent permitted by applicable law and directors’ and officers’ liability insurance coverage for not less than six years following termination of his employment.

 

In addition, on November 20, 2026, Mr. Caplon was granted an option to purchase 170,000 ordinary shares of the Company, nominal value €0.01 per share, under the Plan (the “Promotion Option”). The Promotion Option has an exercise price per share equal to the closing price of an ordinary share on the Nasdaq Capital Market on the date of grant, and a term of ten years. The Promotion Option will vest in eighteen substantially equal monthly installments on each monthly anniversary of the date of grant, subject to Mr. Caplon’s continued employment through each vesting date and to the accelerated vesting provisions of the Employment Agreement described above.

 

There are no arrangements or understandings between Mr. Caplon and any other person pursuant to which Mr. Caplon was appointed Chief Financial Officer of the Company. Mr. Caplon does not have any family relationship with any of the Company’s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Mr. Caplon does not have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.

 

The foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

1

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Employment Agreement, dated November 20, 2026, by and between David Caplon and Quantum Cyber N.V.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  QUANTUM CYBER N.V.
     
Date: November 20, 2026 By: /s/ David Lazar
  Name: David Lazar
  Title: Chief Executive Officer

 

3

 

Filing Exhibits & Attachments

5 documents

Keep reading